NFKB1 and breast cancer: It is therefore suggested that targeting NF-κB may be of value in the treatment of breast cancer related osteolysis (Marino et al., 2017), and the administration of PTL might be effective in preventing breast cancer mediated osteolysis (Chen et al., 2009; Idris et al., 2009).